BAY-2253651

N/A

Report date: 2024/09/02 20:00:48

Base Information

Drug NameBAY-2253651
Drug Alias NameBAY-2253651
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel blockers
TargetsPotassium channel
Therapy Area/IndicationsSleep Apnea, Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AG
Active IndicationsN/A
Inactive IndicationsSleep Apnea, Obstructive

Other Information

ATC CodeN/A
Related LinksN/A